Loading…
Lobbying Spend
—
Filings
44
Firms Hired
1
Active Period
2005–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Lower Costs, More Transparency Act
2024 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency, 340B
Client expense: — · Firm income: $70,000
Matched citations: H.R. 5378
Lower Costs, More Transparency Act
2024 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency, 340B
Client expense: — · Firm income: $70,000
Matched citations: H.R. 5378
Access to Prescription Digital Therapeutics Act of 2023
2024 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 723 Access to Prescription Drug Therapeutics Act Medicare & Medicaid coverage and payment issues, regulatory and payment issues, IRA implementation
Client expense: — · Firm income: $70,000
Matched citations: S. 723
Lower Costs, More Transparency Act
2024 · second_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency
Client expense: — · Firm income: $70,000
Matched citations: H.R. 5378
Access to Prescription Digital Therapeutics Act of 2023
2024 · second_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 723 Access to Prescription Drug Therapeutics Act Medicare & Medicaid coverage and payment issues, regulatory and payment issues, IRA implementation
Client expense: — · Firm income: $70,000
Matched citations: S. 723
Lower Costs, More Transparency Act
2024 · first_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency
Client expense: — · Firm income: $70,000
Matched citations: H.R. 5378
Lower Costs, More Transparency Act
2023 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, pricing, transparency
Client expense: — · Firm income: $70,000
Matched citations: H.R. 5378
Lower Costs, More Transparency Act
2023 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, pricing, transparency
Client expense: — · Firm income: $70,000
Matched citations: H.R. 5378
Transparent PRICE Act
2023 · second_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.3281 Transparent P.R.I.C.E Act S.1339 the Pharmacy Benefit Manager Reform Act IRA implementation, prescription drug pricing, prescription drug access and affordability, pricing, transparency
Client expense: — · Firm income: $70,000
Matched citations: H.R.3281
Pharmacy Benefit Manager Reform Act
2023 · second_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.3281 Transparent P.R.I.C.E Act S.1339 the Pharmacy Benefit Manager Reform Act IRA implementation, prescription drug pricing, prescription drug access and affordability, pricing, transparency
Client expense: — · Firm income: $70,000
Matched citations: S.1339
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.2617, Consolidated Appropriations Act, 2023
Client expense: — · Firm income: $80,000
Matched citations: H.R.2617
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 prescription drug pricing, prescription drug access and affordability, pricing, transparency, user fees
Client expense: — · Firm income: $80,000
Matched citations: H.R.2617
Inflation Reduction Act of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 prescription drug pricing, prescription drug access and affordability, pricing, transparency, user fees
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5376
Food and Drug Amendments of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 prescription drug pricing, prescription drug access and affordability, pricing, transparency, user fees
Client expense: — · Firm income: $80,000
Matched citations: H.R. 7667
S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 prescription drug pricing, prescription drug access and affordability, pricing, transparency, user fees
Client expense: — · Firm income: $80,000
Matched citations: S. 4348
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 prescription drug pricing, prescription drug access and affordability, pricing, transparency, user fees
Client expense: — · Firm income: $80,000
Matched citations: H.R.2617
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.2617, Consolidated Appropriations Act, 2023
Client expense: — · Firm income: $80,000
Matched citations: H.R.2617
Inflation Reduction Act of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 prescription drug pricing, prescription drug access and affordability, pricing, transparency, user fees
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5376
Food and Drug Amendments of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 prescription drug pricing, prescription drug access and affordability, pricing, transparency, user fees
Client expense: — · Firm income: $80,000
Matched citations: H.R. 7667
S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 prescription drug pricing, prescription drug access and affordability, pricing, transparency, user fees
Client expense: — · Firm income: $80,000
Matched citations: S. 4348
Inflation Reduction Act of 2022
2022 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act prescription drug pricing, prescription drug access and affordability, pricing, transparency, user fees
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5376
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
2022 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023
Client expense: — · Firm income: $80,000
Matched citations: H.R. 6833
Food and Drug Amendments of 2022
2022 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act prescription drug pricing, prescription drug access and affordability, pricing, transparency, user fees
Client expense: — · Firm income: $80,000
Matched citations: H.R. 7667
S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act prescription drug pricing, prescription drug access and affordability, pricing, transparency, user fees
Client expense: — · Firm income: $80,000
Matched citations: S. 4348
Consolidated Appropriations Act, 2022
2022 · second_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2471, Consolidated Appropriations Act 2022 government funding, deficit reduction, reconciliation, FY2022 budget, appropriations
Client expense: — · Firm income: $70,000
Matched citations: H.R. 2471
Source: Senate LDA